- Home
- EIG vs KURA Comparison
EIG vs KURA Comparison
Compare EIG & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIG | KURA |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 933.9M | 830.1M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | EIG | KURA |
|---|---|---|
| Price | $43.66 | $8.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $26.88 |
| AVG Volume (30 Days) | 285.6K | ★ 1.4M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $904,800,000.00 | $104,029,000.00 |
| Revenue This Year | $3.75 | $88.72 |
| Revenue Next Year | N/A | $76.50 |
| P/E Ratio | $16.87 | ★ N/A |
| Revenue Growth | ★ 1.69 | N/A |
| 52 Week Low | $35.73 | $5.41 |
| 52 Week High | $52.29 | $12.49 |
Technical Indicators
Market Signals| Indicator | EIG | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 33.75 |
| Support Level | $43.01 | $8.13 |
| Resistance Level | $45.99 | $9.18 |
| Average True Range (ATR) | 0.94 | 0.42 |
| MACD | -0.24 | -0.05 |
| Stochastic Oscillator | 23.99 | 5.63 |
Price Performance
Historical ComparisonAbout EIG Employers Holdings Inc
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.